Trader consensus favoring no new pandemic before 2028 at 83% implied probability reflects the absence of any novel pathogen with sustained human-to-human transmission and high virulence, despite ongoing monitoring. WHO assessments as of mid-2026 rate the global COVID-19 risk as moderate, with SARS-CoV-2 circulation stable and no evidence of increased severity. Contained outbreaks of Ebola Bundibugyo in the DRC, clade I mpox in Africa, and H5N1 avian influenza in U.S. poultry and dairy cattle show limited spillover and effective containment measures. Enhanced surveillance networks, post-COVID laboratory capacity, and respiratory pathogen preparedness frameworks further reduce near-term escalation risk, though zoonotic threats and seasonal respiratory viruses warrant continued vigilance through 2027.